Product Information
NAPROXEN 500 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0601 per EA under NDC 76282034205. Its NADAC has been published 522 times since Nov 23, 2016.
FDA first approved this application on Aug 24, 2011.
Strength
500 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282034205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA091305FDA Approved
8/24/2011
On Market Since
6/10/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 500 MG TABLET has been published 522 times since Nov 23, 2016, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0601 per EA |
|---|---|
| All-time high | $0.0874 (Aug 12, 2020) |
| All-time low | $0.0497 (Apr 17, 2024) |
| 52-week high | $0.0654 |
| 52-week low | $0.0565 |
| Median price | $0.0684 |
| Average price | $0.0685 |
| Largest weekly change | +33.6% (Jun 19, 2024) |
| Weeks tracked | 522 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 500 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0601 per EA (NDC 76282034205), effective Nov 18, 2026.
How has the price of NAPROXEN 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN 500 MG TABLET has declined 8.3%. It has been tracked across 522 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN 500 MG TABLET?
Since Nov 23, 2016, the NADAC for NAPROXEN 500 MG TABLET has ranged from a low of $0.0497 (Apr 17, 2024) to a high of $0.0874 (Aug 12, 2020), with a median of $0.0684 per EA.
Are there cheaper alternatives to NAPROXEN 500 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 500 MG TABLET, is $0.0580 per EA — about 3% below NAPROXEN 500 MG TABLET.
Who manufactures NAPROXEN 500 MG TABLET?
NAPROXEN 500 MG TABLET (NDC 76282034205) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.